Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Momenta Pharmaceuticals launches phase II/III study of nipocalimab in wAIHA

Aug. 2, 2019

FDA approves Accrufer for iron deficiency in adults

July 29, 2019

First-generation PI3KC2alpha inhibitors as promising antithrombotic agents

July 23, 2019

Discovery and preclinical identification of novel NOX1-selective inhibitor, 2APT-PD06

July 23, 2019

Achillion presents promising data from phase I MAD study of ACH-5228

July 23, 2019

Mimicking bone marrow keeps cultured blood stem cells quiescent

July 18, 2019

Finding MDS' iron fist

July 17, 2019

Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121

July 16, 2019

Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism

July 15, 2019

New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A

July 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...